3-Bromoimidazo[1,2-a]pyridine-6-carbonitrile

Catalog No. :
ACIGZK409
CAS No. :
885950-21-0
Molecular Formula :
C8H4BrN3
Molecular Weight :
222.04

IUPAC Name:3-bromoimidazo[1,2-a]pyridine-6-carbonitrile

3-Bromoimidazo[1,2-a]pyridine-6-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$140.00Login to see priceIn stockIn stock
25g98%$644.00Login to see priceIn stockIn stock
100g98%$2499.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromoimidazo[1,2-a]pyridine-6-carbonitrile
IUPAC Name3-bromoimidazo[1,2-a]pyridine-6-carbonitrile
MDL No.MFCD06659617
Molecular FormulaC8H4BrN3
Molecular Weight222.04
SMILESBrC1=CN=C2C=CC(=CN12)C#N
InChI KeyUOQHWNPVNXSDDO-UHFFFAOYSA-N
Synonym3-bromoimidazo[1,2-a]pyridine-6-carbonitrile | 885950-21-0 | MFCD06659617 | Lactobionicacid | SCHEMBL17102325 | DTXSID80377505 | AKOS005071482 | PB32437 | SY097437 | AM20061587 | CS-0035914 | FT-0680758 | 3-BROMO-6-CYANOIMIDAZO[1,2-A]PYRIDINE | P10387 | EN300-6479672 | 9Y-0808 | A861724
CAS No.885950-21-0
PubChem CID2764571

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACIGZK409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDGT509 route compound structure diagram
    ACHDGT5091146615-52-2 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACIGZK409 route product structure diagram
    ACIGZK409885950-21-0 In Stock
Inquiry

2. ACIGZK409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIGZK409 route product structure diagram
    ACIGZK409885950-21-0 In Stock
Inquiry

Comments (0)